PHC to Transfer Eversense CGM Commercial Operations to Senseonics

MT Newswires Live
01/05

PHC Holdings (TYO:6523) said it will transfer the commercial operations of the Eversense continuous glucose monitoring system from its subsidiary Ascensia Diabetes Care to Senseonics Holdings, according to a Monday filing on the Tokyo Stock Exchange.

The move is part of PHC's portfolio review under its Value Creation Plan 2027, aimed at improving investment efficiency.

The company said further growth of Eversense would require sustained investment and that integrating development, manufacturing and sales under Senseonics would be more efficient.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10